Determination of Iodate in Iodized Salt by Reversed-Phase High-Performance Liquid Chromatography with UV Detection

A method for the determination of iodate was developed by reversed-phase high-performance liquid chromatography with UV detection. Iodate was converted to iodine, which was separated from the matrix using a reversed-phase Ultrasphere C₁₈ column (250 × 4.6 mm, 5 μm) with methanol-1 mmol L^?1 H₃PO₄ (20:80, v/v) as mobile phase at 1.00 mL min^?1 and UV detection at 224 nm. The calibration graph was linear from 0.05 μg mL^?1 to 5.00μg mL^?1 for iodine with a correlation coefficient of 0.9994 (n=7). The detection limit was 0.01 μg mL^?1. The method was successfully applied to the determination of iodate in iodized salt. The recovery was from 96% to 101% and the relative standard deviation was in the range of 1.5% to 2.9%.     

Simultaneous Determination of Three Flavonoids in Rat Plasma by RP-LC After Oral Administration of the Total Flavonoids of Scutellaria barbata

A liquid chromatographic method for the simultaneous determination of three flavonoids, scutellarin (SCU), isoscutellarein-8-O-glucuronide (ISO) and luteolin (LUT) in rat plasma was developed and validated. Following a single-step liquid–liquid extraction with ethyl acetate, the analytes and internal standard (IS) (rutin) were successfully separated on a Diamonsil C₁₈ column using a mobile phase composed of acetonitrile (A)–0.2% phosphoric acid aqueous solution (B) (0–5 min, 20% A–29% A; 5–25 min, 29% A, v/v) at a flow rate of 1.0 mL min^?1. The linear range was 0.044–2.20 μg mL^?1 for SCU, 0.042–2.08 μg mL^?1 for ISO, and 0.056–2.80 μg mL^?1 for LUT, with the correlation coefficients of 0.9995, 0.9989 and 0.9963, respectively. The limit of quantification of SCU, ISO and LUT were 44, 41.6 and 56 ng mL^?1, respectively. The accuracy of assay was between 88.4 and 103.0%. The inter-day and intra-day precisions (RSD) were less than 10.5%. The developed method was simple, rapid and applied successfully to study the pharmacokinetics of SCU, ISO and LUT after oral administration of the total flavonoids of Scutellaria barbata.     

Determination of Ebselen by HPLC: Validation and Application of the Method

Ebselen is an organo-selenium, highly hydrophobic compound that exhibits glutathion peroxidase-like activity. It is now in phase III trials in Japan for investigating its effect on ischemic stroke. We have developed an HPLC method for the determination of Ebselen at ambient temperature and applied it to a patented tablet formulation. The mobile phase composition, detection wavelength and chromatographic conditions were optimized. The optimum conditions are a Waters, C₁₈, (25 cm × 4.6 mm, 5 μm) column, 1% acetic acid: methanol: propanol (40:50:10) (ν/ν) as the mobile phase at a flow rate of 0.7 mL min^?1 and detection at 254 nm (internal standard: benzanilide). The method was validated and calibration curves were constructed depended on the ratios of Ebselen to benzanilide peak areas. The concentration range for Ebselen was 0.82–11.71 μg mL^?1, y=0.4021x + 0.0145 (r²=0.9993). Limit of quantification (LOQ) and limit of detection (LOD) were determined as 1.49 μg mL^?1 and 0.45 μg mL^?1 respectively, based on the blank signal and standard deviation of the peak areas of the minimum concentration of Ebselen. Recovery of Ebselen was found to be 98.70 ± 0.75% for 30 mg of tablet powder and 97.43 ± 0.78% for the 30 mg tablet form. The RSD was found to be 1.27% for 10 replicate injections of 50 μL. The ruggedness of the method was investigated by carrying out the same procedure on different days. There was no significant difference between 2 and 7 days time periods. The HPLC method is compared to a spectrophotometric method.     

Development and validation of a generic RP‐HPLC PDA method for the simultaneous separation and quantification of active ingredients in cold and cough medicines

A novel generic reverse phase high performance liquid chromatography (RP‐HPLC) method is developed and validated for simultaneous determination of seven pharmaceutically active ingredients, namely, acetaminophen, dextromethorphan, doxylamine, phenylephrine, guaifenesin, caffeine and aspirin. All seven ingredients were quantified in soft gel, syrup and tablet formulations of the over‐the‐counter US‐marketed products, as per the guidelines of the International Conference on Harmonization. The separation was achieved in a 16 min run time on an Agilent Zorbax Phenyl column using a gradient method with two mobile phases. Mobile phase A was 0.15% trifluoro acetic acid in purified water and while mobile phase B was a mixture of acetonitrile and methanol (750:250 v/v) with 0.02% trifluoro acetic acid. The flow rate was 1.0 mL min^?1 and injection volume was 10 μL. Detection was performed at 280 nm using a photodiode array detector. As part of the method validation, specificity, linearity, precision and recovery parameters were verified. The concentration and area relationships were linear (R² > 0.999), over the concentration ranges 20–120 μg mL^?1 for acetaminophen, 75–450 μg mL^?1 for dextromethorphan, 31.25–187.5 μg mL^?1 for doxylamine, 25–150 μg mL^?1 for phenylephrine, 25–150 μg mL^?1 for aspirin, 6.5–39 μg mL^?1 for caffeine and 12–72 μg mL^?1 for guaifenesin. The relative standard deviations for precision and intermediate precision were <1.5%. The proposed RP‐HPLC generic method is applicable for routine analysis of cold and cough over‐the‐counter products.     

An LC–MS/MS method for the quantification of diclofenac sodium in dairy cow plasma and its application in pharmacokinetics studies

An LC–MS/MS method with internal standard tolfenamic acid for determining diclofenac sodium (DCF) in dairy cow plasma was developed and validated. Samples were processed with protein precipitation by cold formic acid–acetonitrile. Determination of DCF was performed using LC–ESI⁺–MS/MS with the matrix‐matched calibration curve. The results showed that the method was sensitive (LOD 2 ng mL^?1, LOQ 5 ng mL^?1), accurate (97.60 ± 5.64%), precise (<10%) and linear in the range of 5–10,000 ng mL^?1. A single intravenous (i.v.) or intramuscular (i.m.) administration of 5% diclofenac sodium injection at a dose of 2.2 mg kg^?1 was performed in six healthy dairy cows according to a two‐period crossover design. The main pharmacokinetic (PK) parameters after a single i.v. administration were as follows: t_1/2β, 4.52 ± 1.71 h; AUC, 77.79 ± 16.76 h μg mL^?1; mean residence time, 5.16 ± 1.11 h. The main PK parameters after a single i.m. administration were as follows: T_max, 2.38 ± 1.19 h; C_max, 7.46 ± 1.85 μg mL^?1; t_1/2β, 9.46 ± 2.86 h; AUC 67.57 ± 13.07 h μg mL^?1. The absolute bioavailability was 87.37 ± 5.96%. The results showed that the diclofenac sodium injection had PK characteristics of rapid absorption and slow elimination, and high peak concentration and bioavailability in dairy cows, and that the recommended clinical dosage of diclofenac sodium injection is 2.2 mg kg^?1.     

Liquid Chromatographic Analysis of Arabinosylcytosin and 1-β-D-Arabinofuranosyluracil in Treatment with Cyclophosphamide and Pirarubicin

A reversed-phase liquid chromatographic (RPLC) method has been developed for determination of arabinosylcytosin (Ara-C) and its metabolite 1-β-D-arabinofuranosyluracil (Ara-U) on a 250 mm × 4.6 mm i.d., 5 μm particle, Diamonsil C₁₈ column. The mobile phase was a mixture of 5% methanol and 95% 10 mmol L⁻¹ phosphate buffer adjusted to pH 5.5. The flow-rate was 1.0 mL min⁻¹ and the injection volume 20 μL. Eluting compounds were detected at 270 nm by use of an ultraviolet detector. Under these LC conditions cyclophosphamide (CTX) and pirarubicin (THP), two other medicines given with Ara-C in clinical treatment, do not interfere with measurement of Ara-C and Ara-U. Individual calibration plots of peak area against concentration generated from analysis of standard solutions were used to calculate the concentrations of Ara-C and Ara-U in sample solutions. The calibration plot was linear in the range 2.5–100 μg mL⁻¹, the average recovery of Ara-C and Ara-U was more than 98% (RSD < 2.5%), and between-day and within-day precision, expressed as relative standard deviation (RSD), were below 4.0%. LOQ for both Ara-C and Ara-U was 2 μg mL⁻¹. The method is rapid, simple, accurate and reproducible, and especially useful for application to patient samples.     

LC-DAD Determination of Calcium Channel Blockers by Using an Experimental Design Approach

A high-performance liquid chromatographic method with diode array detection has been developed for the determination of five 1,4-dihydropyridines: amlodipine, nitrendipine, felodipine, lacidipine and lercanidipine. A fractional design and a central composite design were used. The factors considered in the optimisation process were: percentage of organic modifier, pH of the aqueous buffer, buffer concentration and temperature. The chromatographic separation was performed using a Supelcosil LC-ABZ+Plus C18 column. An optimised mobile phase of acetonitrile-water (70:30, v/v), containing 10 mM CH₃COOH-CH₃COONa pH 5 at a flow rate of 1 mL min^?1 was used. The temperature was set at 30 ± 2 °C. The photometic detection was carried out at 237 nm. The method was applied to the determination of these compounds at μg mL^?1 concentration levels, obtaining intraday repeatabilities values lower than 5% in terms of relative standard deviations, accuracies higher than 98% and detection limits ranged from 0.03 (felodipine) to 0.35 μg mL^?1 (lacidipine). The chromatographic method allowed the analysis of the drugs in their pharmaceutical formulations with a total elution time of 12 min.     

Validated Voltammetric Method for the Simultaneous Determination of Anti‐diabetic Drugs,Linagliptin and Empagliflozin in Bulk,Pharmaceutical Dosage Forms and Biological Fluids

A cobalt oxide nanoparticles (Co₃O₄NPs) and multi walled carbon nanotubes (MWCNTs) modified carbon paste electrodes were used to study the electrochemical behavior of linagliptin and empagliflozin in Britton Robinson buffer solution of pH 8.0 using cyclic and square wave voltammetry. The above mentioned modified electrodes showed highly sensitive sensing and gave an excellent anodic response for both drugs. The peak current varied linearly over the concentration ranges: 3.98×10^?5–1.53×10^?3 mol L^?1 (18.82–723.00 μg/mL) and 7.94×10^?6–1.07×10^?4 mol L^?1 (3.65–48.25 μg/mL) with determination coefficients of 0.9999 and 0.9998 for linagliptin and empagliflozin, respectively. The recoveries and relative standard deviations were found in the following ranges: 98.80 %–102.00 % and 0.23 %–1.90 % for linagliptin and 98.30 %–101.80 % and 0.11 %–1.86 % for empagliflozin. The detection and quantification limits were 1.13×10^?5 and 3.76×10^?5 mol L^?1 (5.34and17.77 μg/mL) for linagliptin, 1.71×10^?6and 5.68×10^?6 mol L^?1 (0.77 and 2.56 μg/mL) for empagliflozin. The proposed sensors have been successfully applied for the determination of the drugs in bulk, pharmaceutical formulations and biological fluids.     

Development and Validation of Atorvastatin by LC–ESI–MS and Application in Bioequivalence Research in Healthy Chinese Volunteers

The aim of this research was to develop a sensitive liquid chromatographic–electrospray ionization–mass spectrometric (LC–MS) method for direct measurement of the concentration of Atorvastatin in human plasma. Plasma samples (1 mL) were extracted with 3 mL ethyl acetate, and by a simple reversed-phase chromatography. Pitavastatin was used as internal standard (IS). The LOQ was 0.25 ng mL^?1 (RSD 4.24%). The assay was linear from 0.25–20 ng mL^?1. And the correlation coefficient for the calibration regression line was 0.9996 or better. Intra-day and inter-day accuracy were better than 15%. The method has been successfully used for a pharmacokinetic study with human subjects. A two-period crossover designed bioequivalence research was also progressed in healthy Chinese volunteers. Among the pharmacokinetic data obtained, T _max was 1.36 ± 0.68 h for reference formulation and 0.81 ± 0.54 h for test formulation. C _max was 8.54 ± 5.06 ng mL^?1 for reference formulation and 9.54 ± 3.68 ng mL^?1 for test formulation. t _1/2 was 8.50 ± 2.74 h for reference formulation and 9.24 ± 3.17 h for test formulation. AUC _0?48h was 54.77 ± 21.82 h ng mL^?1 for reference formulation and 55.66 ± 20.91 h ng mL^?1 for test formulation. The method was successfully applied to the study of pharmacokinetics of Atorvastatin in healthy Chinese volunteers.     

Pulse perturbation technique for determination of piroxicam in pharmaceuticals using an oscillatory reaction system

A simple and reliable novel kinetic method for the determination of piroxicam (PX) was proposed and validated. For quantitative determination of PX, the Bray-Liebhafsky (BL) oscillatory reaction was used in a stable non-equilibrium stationary state close to the bifurcation point. Under the optimized reaction conditions (T = 55.0°C, [H₂SO₄]₀ = 7.60×10^?2 mol L^?1, [KIO₃]₀ = 5.90×10^?2 mol L^?1, [H₂O₂]₀ = 1.50×10^?1 mol L^?1 and j ₀ = 2.95×10^?2 min^?1), the linear relationship between maximal potential shift ΔE _m , and PX concentration was obtained in the concentration range 11.2–480.5 μg mL^?1 with a detection limit of 9.9 μg mL^?1. The method had a rather good sample throughput of 25 samples h^?1 with a precision RSD = 4.7% as well as recoveries RCV ≤ 104.4%. Applicability of the proposed method to the direct determination of piroxicam in different pharmaceutical formulations (tablets, ampoules and gel) was demonstrated.      

Determination of Fluoride in Water by Reversed-Phase High-Performance Liquid Chromatography using F−-La3+-Alizarin Complexone Ternary Complex

A method for the determination of fluoride by reversed-phase, high-performance liquid chromatography (RP-HPLC) is described. Fluoride, La³⁺ and alizarin complexone form F-La³⁺-alizarin complexone ternary complex, which is separated from the matrix on a RP, Ultrasphere C₁₈ column (250 × 4.6 mm, 5 μm) using methanol-water (19:81, v/v) mobile phase at 1.00 mL min^?1; detection at 568 nm. The calibration graph was linear from 1.0–150 ng mL^?1 for fluoride with a correlation coefficient: 0.9993 (n=6). The detection limit was 0.2 ng mL^?1. The method was successfully applied to the determination of fluoride in river and tap water. Recovery was: 94–102%, RSD in the range: 1.9 –3.6%.     

First Electroanalytical Methodology for the Determination of Hordenine in Dietary Supplements using a Boron‐doped Diamond Electrode

The present work describes the first electrochemical investigation and a simple, rapid and modification‐free electroanalytical methodology for quantification of hordenine (a potent phenylethylamine alkaloid) using a boron‐doped diamond electrode. At optimized square‐wave voltammetric parameters, the observed oxidation peak current in 0.1 M HClO₄ at +1.33 V (vs. Ag/AgCl) increased linearly from 5.0 to 100 μg mL^?1 (3.0×10^?5–6.1×10^?4 M), with detection limit of 1.3 μg mL^?1 (7.8×10^?6 M). The applicability of the developed method was tested with the determination of hordenine in the commercial dietary supplement formulations.     

Validated LC Determination of the Piroxicam-β-Cyclodextrin Inclusion Complex in Tablets and in Human Plasma

A simple, rapid, specific, sensitive HPLC method has been developed for the determination of piroxicam in the tablet dosage form and in human plasma. The method totally eliminates solvent extraction and time-consuming separation procedures. Plasma proteins were precipitated by addition of 3:1 (v/v) acetonitrile-methanol, ZnSO₄, and MgSO₄ and the supernatant was injected directly on to a 250 mm × 4.6 mm, 5 μm particle Spherisorb analytical column. Acetonitrile-methanol-0.04 mol L^?1 KH₂PO_4, 40:10:50 (v/v); pH 3.8, was used as mobile phase. The drug was detected by UV detection at 330 nm. The response was linear over the range of 0.01–10 μg mL^?1 and 0.025–5 μg mL^?1 in mobile phase and human plasma samples, respectively. The proposed method was used without interference from the endogenous substances, for determination of piroxicam in plasma samples obtained from healthy volunteers. The results revealed that the method would be useful in monitoring plasma levels of the drug during pharmacokinetic studies. Assay of piroxicam in its dosage forms for quality-control purposes could also be performed successfully by use of this method.     

Drug screening in human plasma by cloud-point extraction and HPLC

Cloud-point extraction (CPE) with RP-HPLC/DAD detection was used to develop a screen for six model basic drugs (paracetamol, promazine, amitriptyline, nortriptyline, clomipramine and chlorpromazine) in human plasma. These drugs’ varied hydrophobicities entail different affinities for the micelle-rich phase and CPE extraction efficiencies. Extraction recovery (except paracetamol) was above 80% and reproducibility (RSD%) ranged from 2.88 to 10.26 intraday and from 3.12 to 12.33 interday. The limits of detection were: 0.125 μg mL^?1 (promazine and chlorpromazine), 0.25 μg mL^?1 (amitriptyline and nortriptyline) and 0.5 μg mL^?1 (paracetamol and clomipramine). The method was linear over the ranges: 0.125–1.0 μg mL^?1 (promazine and chlorpromazine), 0.25–1.0 μg mL^?1 (amitriptyline and nortriptyline), 0.5–1.0 μg mL^?1 (clomipramine) and 0.5–10 μg mL^?1 (paracetamol). The procedure is a good alternative to the SPE or LLE sample preparation usually used.     

Flow injection spectrophotometric determination of ascorbic acid in soft drinks and beer

Two spectrophotometric methods, a photochemical and a non-photochemical, for the determination of ascorbic acid in soft drinks and beer using a flow-injection system are proposed. The non-photochemical method is based on the redox reaction that takes place between ascorbic acid and Fe(III), yielding dehydroascorbic acid and Fe(II). Fe(II) reacts with 1,10-phenantroline, originating the reddish orange Fe(phen)₃ ²⁺ complex (ferroin). This complex is spectrophotometrically monitored at 512 nm, and the signal is directly related to the concentration of ascorbic acid in the sample. The photochemical method has the same basis, nevertheless, uses the irradiation with visible light to enhance the redox reaction and so achieve higher sensitivities in the analysis. The non-photochemical method shows a linear range between 5 and 80 μg mL^?1, with a relative standard deviation of 1.6% (n = 11), a detection limit of 2.7 μg mL^?1 and a sample throughput of ¶60 samples h^?1. The photochemical method shows a linear range between 1 and 80 μg mL^?1, with a relative standard deviation of 1.0% (n = 11), a detection limit of 0.5 μg mL^?1 and a sample throughput of 40 samples h^?1.     

Optimization of dispersive liquid–liquid microextraction with central composite design for preconcentration of chlordiazepoxide drug and its determination by HPLC‐UV

A simple, rapid, and sensitive method based on dispersive liquid–liquid microextraction combined with HPLC‐UV detection applied for the quantification of chlordiazepoxide in some real samples. The effect of different extraction conditions on the extraction efficiency of the chlordiazepoxide drug was investigated and optimized using central composite design as a conventional efficient tool. Optimum extraction condition values of variables were set as 210 μL chloroform, 1.8 mL methanol, 1.0 min extraction time, 5.0 min centrifugation at 5000 rpm min^?1, neutral pH, 7.0% w/v NaCl. The separation was reached in less than 8.0 min using a C₁₈ column using isocratic binary mobile phase (acetonitrile/water (60:40, v/v)) with flow rate of 1.0 mL min^?1. The linear response (r² > 0.998) was achieved in the range of 0.005–10 μg mL^?1 with detection limit 0.0005 μg mL^?1. The applicability of this method for simultaneous extraction and determination of chlordiazepoxide in four different matrices (water, urine, plasma, and chlordiazepoxide tablet) were investigated using standard addition method. Average recoveries at two spiking levels were over the range of 91.3–102.5% with RSD < 5.0% (n = 3). The obtained results show that dispersive liquid–liquid microextraction combined with HPLC‐UV is a fast and simple method for the determination of chlordiazepoxide in real samples.     

Quantitative Determination of Carisoprodol and its Metabolites in Equine Urine and Serum by Liquid Chromatography-Tandem Mass Spectrometry

Cefuroxime is a broad-spectrum second-generation bactericidal cephalosporin antibiotic active against β-lactamase-producing strains. Anti-cefuroxime, the geometric isomer of cefuroxime, might be present in cefuroxime dosage forms as a process-related impurity and possible degradation product. In the work discussed in this paper a precise and sensitive micellar liquid chromatographic (MLC) method for stability testing of cefuroxime axetil and anti-cefuroxime axetil in tablets, using benzoic acid as internal standard, was developed and validated. MLC was performed on an XTerra C₁₈ reversed-phase column at 50 °C with 8:92 (v/v) acetonitrile–20 mM sodium dodecyl sulphate, pH 2.5, as mobile phase at a flow rate of 1.5 mL min^?1. Detection was at 280 nm. Under these conditions the retention time and retention factor were of 6.65 min and 4.57, respectively, for cefuroxime axetil and 11.45 min and 8.59, respectively, for anti-cefuroxime axetil, indicating that the compounds were well separated. RSD values for quantification of cefuroxime axetil and anti-cefuroxime axetil were 0.39 and 1.7%, respectively, indicating the precision of the MLC method was good. The method is sensitive—LOD=0.5 μg mL^?1 and LOQ=1.5 μg mL^?1 for anti-cefuroxime axetil—and reproducible, with good recovery values.     

Spectrophotometric Determination of Selected Antibiotics Using Prussian Blue Reaction

A simple, sensitive and accurate spectrophotometric method has been described for the determination of ampicillin(I), amoxicillin trihydrate(II) and cefazolin sodium(III). The procedure is based on the formation of Prussian Blue (PB) complex. The reaction between the acidic hydrolysis products of antibiotics (T = 60 °C) with mixture of Fe³⁺ and hexacyanoferrate(III) ions was evaluated for the spectrophotometric determination of the mentioned drugs. The maximum absorbance of the colored complex occurs at λ = 700 nm and the molar absorptivity is 3.0 × 10⁴ 1 mol^?1cm^?1. The effect of various parameters such as concentration of K₃Fe(CN)₆ and Fe³⁺, nature and amount of acids used, temperature and time of heating were investigated. Under optimum conditions the linear range of calibration graph was 2.0–12.0, 5.0–13.5 and 3.0–12.0 μg mL^?1 for ampicillin, amoxicillin and cefazolin, respectively. The relative standard deviation for the determination of 10 μg mL^?1 of antibiotics was about 0.5–1.5%. The proposed method was successfully applied to the determination of selected antibiotics from pharmaceutical preparations. The validity of the method was tested by the official methods and by the recovery studies of standard addition to pharmaceuticals.     

Simultaneous Determination of Berberine and Palmatine in Rabbit Plasma by LC-MS–MS and Its Application in Pharmacokinetic Study After Oral Administration of Coptidis and Coptidis–Gardeniae Couple Extract

A valid and sensitive LC-MS–MS method is adopted for pharmacokinetics study of berberine and palmatine in rabbit plasma. After mixing with internal standard tetrahydroberberine, plasma samples were pretreated with 1.5 mL acetonitrile. Chromatographic separation was on a C₁₈ column using a mixture of water (containing 10 mmol L^?1 ammonium acetate, pH 3.5) and acetonitrile (50∶50, v/v) as mobile phase. The detection was performed by selected ion monitoring mode via electrospray ionization source operating in the positive ionization mode. The method was linear over the concentration range of 2.0–200.0 ng mL^?1 for berberine and 1.0–100.0 ng mL^?1 for palmatine. The lowest limits of quantitation (LLOQ) were 2.0 ng mL^?1 for berberine and 1.0 ng mL^?1 for palmatine. The intra- and inter-day precision values were less than 14.3% and the deviations were within ±11.0%. The fully validated LC-MS–MS method has been successfully applied to a pharmacokinetic study of berberine, palmatine in rabbit plasma after oral administration of Coptidis and coptidis–gardeniae couple extract. The results indicated that the plasma profiles of the two compounds in rabbit confirmed to one-compartment open model and the combinational utilization with Gardeniae could increase the bioavailability of berberine and palmatine, the two major active components of Coptidis.     

Flow-injection chemiluminescence determinations for human blood lead using controlled reagent release technology

A flow-through CL method for the determination of lead combined with controlled-reagent-release technology has been developed. Chemiluminescence (CL) reagents luminol and potassium permanganate were immobilized on anion exchange resin by electrostatic interaction. Lead ion was determined by its enhancing effect on the CL reaction between luminol and potassium permanganate. Both luminol and potassium permanganate were eluted from the anion exchange resin column by sodium phosphate solution. The linear range of the system was 10 μg mL^?1, and the detection limit was 5?×?10^–9 g mL^?1 lead (3σ). A complete analysis could be performed in 1 min with a relative SD 3.2% (1.0?×?10^–7 g mL^?1, n?=?9). The column shows remarkable stability and can be reused over 350 times and 21 days. The method has been applied to determine lead in human blood samples.